Patient Diagnostic Journey and Time to Diagnosis in Axial Spondyloarthritis: A Retrospective Cohort Study Using US Claims Data
This study shows that diagnostic delay is a challenge for patients with axSpA in the US, despite numerous back pain consultations, specialist visits, and diagnostic tests. These findings highlight the urgent need for strategies to enhance recognition of axSpA and improve the patient diagnostic journey.
Authors
- Julie Gandrup (ORCID: https://orcid.org/0000-0002-4109-4889)
- Marina Magrey (ORCID: https://orcid.org/0000-0002-6520-5619)
- Kathrin Haeffs
- Maureen Dubreuil (ORCID: https://orcid.org/0000-0002-6253-1515)
- E. I. IVANOV
Institutions
- Boston University (US)
- University Hospitals of Cleveland (US)
- Universitetshospitalernes Center for Sundhedsfaglig Forskning (DK)
- UCB Pharma (Germany) (DE)
- Case Western Reserve University (US)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1007/s40744-025-00791-5
- Citations
- 1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- UCB